EUCTR2010-023300-27-FI进行中（未招募）不适用
Ability of the new Vero-cell-derived inactivated Japanese encephalitis vaccine (IXIARO) to elicit a booster response in travellers previously vaccinated with traditional mouse-brain derived vaccine (JE-MB)
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 入组人数
- 120
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •- male and female travelers over 18 years of age
- •- general good health
- •- written informed consent
- •- ability to attend all visits scheduled in the study
- •- travelers who have previously received a primary series of 2 or 3 doses of JE-MB and are now given a booster vaccination with Japanese Encephalitis Vaccine - GCC or IXIARO because of their upcoming trip to Asia
- •- travelers who are previously unvaccinated against JE and are given the primary vaccination series with IXIARO at the travel clinic because of their upcoming trip to Asia
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years)
- •F.1.3.1 Number of subjects for this age range
排除标准
- •- age below 18 years
- •- acute disease at the enrollment
- •- pregnancy or lactation
- •- known immunodeficiency or immune suppressive treatment
- •- any chronic illness that might interfere with the immune response
- •- alcohol or drug abuse
- •- any clinically significant history of known or suspected anaphylaxis or hypersensitivity based on the judgement of the investigator
研究者
相似试验
招募中
不适用
Establishment of immortalized cells involved in endometriosis and ovarian tumor.endometriosis, ovarian cystJPRN-UMIN000030867agoya University40
已完成
不适用
Safety and effectiveness of boosting healthy adults with new cell-culture-derived JE vaccine (JESPECT), where mouse-brain-derived vaccine (JEVAX) has previously been administered.Japanese encephalitisPublic Health - Other public healthInfection - Other infectious diseasesInflammatory and Immune System - Normal development and function of the immune systemACTRN12611001090909Csongor Oltvolgyi150
已完成
不适用
Effect of a bioactive solution on the duration of diarrhoea in adultsISRCTN10890482iveLeaf Inc150
进行中（未招募）
不适用
AN OPEN LABEL PHASE III STUDY OF A VERO CELL-DERIVED WHOLE VIRUS H5N1 INFLUENZA VACCINE TO ASSESS THE IMMUNOGENICITY AND SAFETY AND TO INVESTIGATE THE NEED FOR AND TIMING OF A BOOSTER VACCINATION - Phase 3 H5N1 Influenza Vaccine StudyH5N1 Influenza vaccination in healthy subjectsMedDRA version: 9.1Level: LLTClassification code 10022000Term: InfluenzaEUCTR2006-006307-37-DEBaxter Innovations GmbH550
进行中（未招募）
不适用
AN OPEN LABEL PHASE III STUDY OF A VERO CELL-DERIVED WHOLE VIRUS H5N1 INFLUENZA VACCINE TO ASSESS THE IMMUNOGENICITY AND SAFETY AND TO INVESTIGATE THE NEED FOR AND TIMING OF A BOOSTER VACCINATION - Phase 3 H5N1 Influenza Vaccine StudyH5N1 Influenza vaccination in healthy subjectsMedDRA version: 9.1Level: LLTClassification code 10022000Term: InfluenzaEUCTR2006-006307-37-ATBaxter Innovations GmbH550